Precision Business Insights
Portfolio

 

Research Reports

Autologous Cell Therapy Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2014-2018 and Forecast 2019-2025

Global Autologous Cell Therapy Market: By Source (Bone Marrow, Epidermis, and Others), By Application (Cancer, Neurodegenerative Diseases, Wound Healing, Orthopedic, CVD, Autoimmune Diseases, and Others), By End User (Hospitals, Ambulatory Centers, and Research Centers), and Geography

 

 

Global Autologous Cell Therapy Market:

The global autologous cell therapy market estimated to be valued US$ XX. Mn in 2018 and poised to grow at significant CAGR over 2019-2025 owing to increase in prevalence of various incurable diseases and autologous stem cell therapy is an effective and safer technology when compared to that of the existing transplantation technologies in the market. Moreover, benefits such as reduction of risks which are associated with bio-incompatibility, disease transmission and immunological reactions drives the growth of the market.

Increasing prevalence of Cancer across the world

Sedentary lifestyle and poor dietary choices has fuelled the growth of the malignancy across the world. As per American Cancer Society, a million people are suffering from cancer in United States alone. Moreover, rising funds form the government and private organizations support in cell therapy clinical trials and proven effectiveness of products coupled declining prices of stem cell therapies drives the growth of the market.

North America Accounts for Larger Market Revenue Share in Global Autologous Cell Therapy Market

North America accounted for larger revenue share in global autologous cell therapy market with significant CAGR owing to increased investments for treatment facilities and presence of large number of companies and strong regulatory framework to promote cell therapies and high cost for the therapy in United States drives the growth of the market. Asia Pacific region is expected to be the fastest growing region over the forecast period owing to rising medical tourism to the region and improvements in healthcare infrastructure in countries like India and China.

Competition Assessment

Key player’s profiles in the global autologous cell therapy market include:

  • Brainstorm Cell Therapeutics (U.S.)
  • Vericel Corporation
  • Holostem Advanced Therapies
  • Osiris Therapeutics
  • Opexa Therapeutics
  • BioTime Inc.
  • Phamicell Co. Inc.

 

.Key Findings of the Report:

 

  • Global autologous cell therapy market expanding at significant CAGR over 2018 to 2024 owing to increasing prevalence of cancer across globe and rising funds from the government and market players receiving approvals for the products.
  • Based on Application, cancer segment autologous cell therapy accounted for larger market revenue share in 2018 and projected gain market revenue share over the forecast period
  • Players focusing on innovation of newer products and collaboration strategies to retain market position in global autologous cell therapy market

 

Global Autologous Cell Therapy Market Report Description:

 

Global autologous cell therapy market report gives comprehensive outlook on autologous cell therapy across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The report on global autologous cell therapy market gives historical, current, and future market sizes (US$ Mn) on the basis of source, application, end user, and region. This report studies global autologous cell therapy market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, global autologous cell therapy market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global autologous cell therapy market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the global autologous cell therapy market report include suppliers, manufacturers, marketers, policy makers, and healthcare service providers engaged in global autologous cell therapy products.

 

Detailed Segmentation

 

By Source  

  • Bone Marrow
  • Epidermis
  • Others

By Application  

  • Cancer
  • Neurodegenerative Diseases
  • Wound Healing
  • orthopedic
  • CVD
  • Autoimmune
  • Others

By End User

  • Hospitals
  • Ambulatory Centers
  • Research Centers

Geography

 

North America

  • US
  • Canada

Europe

  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
  • Poland
  • Rest of Europe

Asia-Pacific

  • Japan
  • China
  • India
  • Australia & New Zealand
  • ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
  • South Korea
  • Rest of Asia-Pacific

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Venezuela
  • Rest of Latin America

Middle East and Africa (MEA)

  • Gulf Cooperation Council (GCC) Countries
  • Israel
  • South Africa
  • Rest of MEA

 

Key Features of the Report:

 

  • The report provides granular level information about the market size, regional market share, historic market (2014-2018) and forecast (2019-2025)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
  1. Executive Summary
  2. Global Autologous Cell Therapy Market Introduction

2.1. Global Autologous Cell Therapy Market – Taxonomy

2.2. Global Autologous Cell Therapy Market –Definitions

2.2.1. By Source

2.2.2. By Application

2.2.3. By End User

  1. Global Autologous Cell Therapy Market Dynamics

3.1. Drivers

3.2. Restraints

3.3. Opportunities/Unmet Needs of the Market

3.4. Trends

3.5. Global Autologous Cell Therapy Market Dynamics – Factors Impact Analysis

  1. Global Autologous Cell Therapy Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025

4.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)

4.3. Market Opportunity Analysis

  1. Global Autologous Cell Therapy Market Forecast, By Source, 2014 – 2018 and Forecast, 2019 – 2025

5.1. Bone Marrow

5.1.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.1.3. Market Opportunity Analysis

5.2. Epidermis

5.2.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.2.3. Market Opportunity Analysis

5.3. Others

5.3.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.3.3. Market Opportunity Analysis

  1. Global Autologous Cell Therapy Market Forecast, By Application, 2014 – 2018 and Forecast, 2019 – 2025

6.1. Cancer

6.1.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.1.3. Market Opportunity Analysis

6.2. Neurodegenerative Diseases

6.2.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.2.3. Market Opportunity Analysis

6.3. Wound Healing

6.3.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.3.3. Market Opportunity Analysis

6.4. Orthopedic

6.4.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.4.3. Market Opportunity Analysis

6.5. CVD

6.5.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.5.3. Market Opportunity Analysis

6.6. Autoimmune

6.6.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.6.3. Market Opportunity Analysis

6.7. Others

6.7.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

6.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.7.3. Market Opportunity Analysis

  1. Global Autologous Cell Therapy Market Forecast, By End User, 2014 – 2018 and Forecast, 2019 – 2025

7.1. Hospitals

7.1.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.1.3. Market Opportunity Analysis

7.2. Ambulatory Centers

7.2.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.2.3. Market Opportunity Analysis

7.3. Research Centers

7.3.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.3.3. Market Opportunity Analysis

  1. Global Autologous Cell Therapy Market Forecast, By Region, 2014 – 2018 and Forecast, 2019 – 2025

8.1. North America

8.1.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.1.3. Market Opportunity Analysis

8.2. Europe

8.2.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.2.3. Market Opportunity Analysis

8.3. Asia Pacific

8.3.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.3.3. Market Opportunity Analysis

8.4. Latin America

8.4.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.4.3. Market Opportunity Analysis

8.5. The Middle East & Africa

8.5.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.5.3. Market Opportunity Analysis

8.6. Global Autologous Cell Therapy Market – Opportunity Analysis Index, By Source, By Application, By End User, and Region, 2019 – 2025

  1. North America Autologous Cell Therapy Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025

9.1. Source Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

9.1.1. Bone Marrow

9.1.2. Epidermis

9.1.3. Others

9.2. Application Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

9.2.1. Cancer

9.2.2. Neurodegenerative Diseases

9.2.3. Wound Healing

9.2.4. orthopedic

9.2.5. CVD

9.2.6. Autoimmune

9.2.7. Others   

9.3. End User Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

9.3.1. Hospitals

9.3.2. Ambulatory Centers

9.3.3. Research Centers

9.4. Country Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

9.4.1. U.S.

9.4.2. Canada

9.5. North America Autologous Cell Therapy Market – Opportunity Analysis Index, By Source, By Application, By End User, and Country, 2019 – 2025

9.6. North America Autologous Cell Therapy Market Dynamics – Trends

  1. Europe Autologous Cell Therapy Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025

10.1. Source Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

10.1.1. Bone Marrow

10.1.2. Epidermis

10.1.3. Others

10.2. Application Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

10.2.1. Cancer

10.2.2. Neurodegenerative Diseases

10.2.3. Wound Healing

10.2.4. orthopedic

10.2.5. CVD

10.2.6. Autoimmune

10.2.7. Others   

10.3. End User Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

10.3.1. Hospitals

10.3.2. Ambulatory Centers

10.3.3. Research Centers

10.4. Country Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

10.4.1. U.K.

10.4.2. Germany

10.4.3. France

10.4.4. Italy

10.4.5. Spain

10.4.6. Russia

10.4.7. Rest of Europe

10.5. Europe Autologous Cell Therapy Market – Opportunity Analysis Index, By Source, By Application, By End User, and Country, 2019 – 2025

10.6. Europe Autologous Cell Therapy Market Dynamics – Trends

  1. Asia Pacific Autologous Cell Therapy Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025

11.1. Source Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

11.1.1. Bone Marrow

11.1.2. Epidermis

11.1.3. Others

11.2. Application Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

11.2.1. Cancer

11.2.2. Neurodegenerative Diseases

11.2.3. Wound Healing

11.2.4. orthopedic

11.2.5. CVD

11.2.6. Autoimmune

11.2.7. Others   

11.3. End User Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

11.3.1. Hospitals

11.3.2. Ambulatory Centers

11.3.3. Research Centers

11.4. Country Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

11.4.1. China

11.4.2. Japan

11.4.3. India

11.4.4. ASEAN Counties

11.4.5. Philippines

11.4.6. Rest of Asia Pacific

11.5. Asia Pacific Autologous Cell Therapy Market – Opportunity Analysis Index, By Source, By Application, By End User, and Country, 2019 – 2025

11.6. Asia Pacific Autologous Cell Therapy Market Dynamics – Trends

  1. Latin America Autologous Cell Therapy Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025

12.1. Source Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

12.1.1. Bone Marrow

12.1.2. Epidermis

12.1.3. Others

12.2. Application Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

12.2.1. Cancer

12.2.2. Neurodegenerative Diseases

12.2.3. Wound Healing

12.2.4. orthopedic

12.2.5. CVD

12.2.6. Autoimmune

12.2.7. Others   

12.3. End User Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

12.3.1. Hospitals

12.3.2. Ambulatory Centers

12.3.3. Research Centers

12.4. Country Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

12.4.1. Mexico

12.4.2. Brazil

12.4.3. Argentina

12.4.4. Chile

12.4.5. Rest of Latin America

12.5. Latin America Autologous Cell Therapy Market – Opportunity Analysis Index, By Source, By Application, By End User, and Country, 2019 – 2025

12.6. Latin America Autologous Cell Therapy Market Dynamics – Trends

  1. Middle East and Africa Autologous Cell Therapy Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025

13.1. Source Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

13.1.1. Bone Marrow

13.1.2. Epidermis

13.1.3. Others

13.2. Application Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

13.2.1. Cancer

13.2.2. Neurodegenerative Diseases

13.2.3. Wound Healing

13.2.4. orthopedic

13.2.5. CVD

13.2.6. Autoimmune

13.2.7. Others   

13.3. End User Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

13.3.1. Hospitals

13.3.2. Ambulatory Centers

13.3.3. Research Centers

13.4. Country Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

13.4.1. GCC Countries

13.4.2. South Africa

13.4.3. Saudi Arabia

13.4.4. Turkey

13.4.5. Rest of MEA

13.5. Middle East and Africa Autologous Cell Therapy Market – Opportunity Analysis Index, By Source, By Application, By End User, and Country, 2019 – 2025

13.6. Middle East and Africa Autologous Cell Therapy Market Dynamics – Trends

  1. Competition Landscape

14.1. Strategic Dashboard of Top Market Players

14.2. Company Profiles (Introduction, Financial Analysis, Key Developments, Strategies, and SWOT Analysis)

14.2.1. Brainstorm Cell Therapeutics (U.S.)

14.2.2. Vericel Corporation

14.2.3. Holostem Advanced Therapies

14.2.4. Osiris Therapeutics

14.2.5. Opexa Therapeutics

14.2.6. BioTime Inc.

14.2.7. Phamicell Co. Inc. 

  1. Research Methodology
  2. Key Assumptions and Acronyms
$ 3,000.00$ 8,900.00
Clear selection

Select License Type

Databank $ 3,000.00
spinner
Single User $ 4,400.00
spinner
Multiple User $ 6,600.00
spinner
Corporate User $ 8,900.00
spinner
buy now spinner
FacebookTwitterLinkedinEmail

Our Clients

Testimonials